72 items related to 'Togo'
(Page 2 of 4)
-
Q&A with our experts: SDG 3 progress on maternal and child health
-
Our story
-
Resources: Annual review :
Trustees' report and financial statements for the year to 31 March 2024
Malaria Consortium's trustees present their report and the audited financial statements for the year which ended 31 March 2024.
-
Resources: Journal article :
Using the role model approach to optimise caregiver administration of sulfadoxine-pyrimethamine amodiaquine to children aged 3–59 months in Burkina Faso, Chad and Togo
Caregivers perceived a role model approach to be helpful for improving drug administration during seasonal malaria chemoprevention. Effective promotion via community structures is recommended for…
-
completedImproving the availability, coverage and quality of antenatal care and malaria in pregnancy services in six districts of the Plateaux region in Togo
Improving the availability, coverage and quality of antenatal care and malaria in pregnancy services in six districts of the Plateaux region in Togo.
-
Resources: Project brief :
Zero-dose project
The Zero-dose project aims to integrate the identification and immunisation of zero-dose and undervaccinated children with existing seasonal malaria chemoprevention campaigns.
-
completedZero-dose project
Through the zero-dose project, Malaria Consortium aims to improve immunisation coverage in Togo by integrating the search for zero-dose and under-immunised children into the country's seasonal…
-
Malaria Consortium global capacity statement
-
Blog :
Pioneering solutions for community health: Africa's trailblazers
Many countries in Africa have grappled with significant challenges in providing accessible and quality healthcare to their populations due to insufficient infrastructure, shortages of medical…
-
Resources: Project brief :
Seasonal malaria chemoprevention
Malaria Consortium is a leading implementer of seasonal malaria chemoprevention (SMC) and carries out pioneering research to strengthen the quality and effectiveness of this life-saving intervention.
-
Resources: Capacity statement :
Global capacity statement
Our global capacity statement describes our approach and expertise and provides an overview of the key areas of our work.
-
Resources: Project report :
Coverage and quality of seasonal malaria chemoprevention supported by Malaria Consortium in 2023
This report outlines our methods for monitoring coverage of our SMC programme and the quality of its delivery in 2023.
-
Resources: Project report :
Malaria Consortium’s seasonal malaria chemoprevention programme: Philanthropy report 2023
This report summarises achievements and challenges in areas where Malaria Consortium used philanthropic funding for SMC in 2023.
-
Resources: Annual review :
Trustees' report and financial statements for the year to 31 March 2023
Malaria Consortium's trustees present their report and the audited financial statements for the year which ended 31 March 2023.
-
Resources: Presentation :
Opportunities for learning through a community of practice: How flexible and adaptable guidelines create opportunities for learning and rapid improvement in implementation
A community of practice for perennial malaria chemoprevention will enable countries to share experiences and learn from one another and avoid duplication of efforts.
-
Resources: Annual review :
20 years of impact: Saving lives, transforming communities
On this, the 20th anniversary of Malaria Consortium, we reflect on the journey so far and provide insights into what we have achieved and how we seek to address the key challenges that remain.
-
Resources: Capacity statement :
Integrated community case management
With vast experience in supporting iCCM initiatives across Africa and Asia, Malaria Consortium offers technical assistance to ministries of health to implement and improve their iCCM programmes.
-
Resources: Journal article :
Predictors of caregiver adherence to administration of amodiaquine during delivery of seasonal malaria chemoprevention in Nigeria, Burkina Faso, Chad and Togo
Non-adherence to amodiaquine administration by caregivers has implications for the emergence of antimalarial resistance.
-
Resources: Project report :
Coverage and quality of seasonal malaria chemoprevention supported by Malaria Consortium in 2022
This report outlines our methods for monitoring coverage of our SMC programme and the quality of its delivery in 2022.
-
Resources: Project report :
Malaria Consortium’s seasonal malaria chemoprevention programme: Philanthropy report 2022
This report summarises achievements and challenges in areas where Malaria Consortium used philanthropic funding for SMC.